Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
282 participants
OBSERVATIONAL
2019-12-01
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study Design: An observational cross-sectional survey pilot study using a correlational design with the intention-to-treat principle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Size Matter: A Single Case Experimental Design of Limiting the Depth of Penetration During Intercourse
NCT04052217
The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland
NCT05462171
Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction
NCT02477436
Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: a Randomized Controlled Trial
NCT00636688
Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
NCT04185441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Measurements of the penis erect length and girth were by two doctor-urologists according to the method of Veale D et al. (2015).
Statistical analysis. Two-tailed Student's t-test, Pearson correlation and multivariate tests of the MANOVA and MANCOVA (body height as covariate) were used.
Sample size estimation. In a cross-sectional observational study in assessment of erect penis size of Kazakh adult males we supposed that the primary interest lies in assessment of erect penis sizes in the three cities (k=3). The investigators wish to be 95% sure of detecting when the mean erect penis sizes not exceed 1 mm (i.e., 1-β=0.95, and m1=1, m2=0). The standard deviation of erect penis size is likely to be 1.56 mm (i.e. SD=1.56) with a statistical power of 95% and significance level of 2.5% with the Bonferroni correction based on one-sided hypothesis testing. At the 5% Type I error rate (i.e., α=0.05), the sample size of the survey is 196.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
measurements and questionnaire
paper-based survey administration; erect penis length and girth measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fill out the questionnaire
* BMI ≤ 29.9 kilogram per meter square
* a male who has at least one healthy native child
* no non-communicable chronic diseases.
Exclusion Criteria
* BMI ≥ 30.0 kilogram per meter square
* infertility
* erectile dysfunction, previous pelvic surgery, suspected hypogonadism, penile disease, or deformity
* specific treatment with androgens
* alcohol or drug abuse
* history of alcohol consumption ≥ 30 g/day within the past 5 years.
23 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center, Kazakhstan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kuat Oshakbayev
a principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bibazhar Dukenbayeva, Dr.
Role: STUDY_DIRECTOR
ANADETO medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kuat Pernekulovich Oshakbayev
Astana, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0000187
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.